152 related articles for article (PubMed ID: 22012716)
1. Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients.
Ezzikouri S; Rebbani K; Mostafa A; El Feydi AE; Afifi R; Brahim I; Kitab B; Benazzouz M; Kandil M; Nadifi S; Pineau P; Benjelloun S
J Med Virol; 2011 Dec; 83(12):2096-102. PubMed ID: 22012716
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.
Mah YH; Kao JH; Liu CJ; Chen CL; Chen PJ; Lai MY; Chen DS
Liver Int; 2005 Apr; 25(2):214-9. PubMed ID: 15780041
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis.
Settin A; El-Bendary M; Abo-Al-Kassem R; El Baz R
J Gastrointestin Liver Dis; 2006 Jun; 15(2):131-5. PubMed ID: 16802007
[TBL] [Abstract][Full Text] [Related]
4. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
[TBL] [Abstract][Full Text] [Related]
5. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
[TBL] [Abstract][Full Text] [Related]
6. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
7. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
9. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; El Kihal L; Afifi R; Benazzouz M; Hassar M; Chafik A; Pineau P; Benjelloun S
Arch Med Res; 2008 Feb; 39(2):236-41. PubMed ID: 18164971
[TBL] [Abstract][Full Text] [Related]
11. HFE gene C282Y, H63D and S65C mutations frequency in the Transylvania region, Romania.
Trifa AP; Popp RA; Militaru MS; Farcaş MF; Crişan TO; Gana I; Cucuianu A; Pop IV
J Gastrointestin Liver Dis; 2012 Jun; 21(2):177-80. PubMed ID: 22720307
[TBL] [Abstract][Full Text] [Related]
12. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population.
Jain S; Agarwal S; Tamhankar P; Verma P; Choudhuri G
Indian J Gastroenterol; 2011 Jul; 30(4):161-5. PubMed ID: 21822737
[TBL] [Abstract][Full Text] [Related]
14. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the HFE gene in patients with hepatocellular carcinoma.
Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
[TBL] [Abstract][Full Text] [Related]
17. HFE gene mutations in patients with alcoholic liver disease. A prospective study from northwestern Poland.
Raszeja-Wyszomirska J; Kurzawski G; Zawada I; Suchy J; Lubinski J; Milkiewicz P
Pol Arch Med Wewn; 2010 Apr; 120(4):127-31. PubMed ID: 20424537
[TBL] [Abstract][Full Text] [Related]
18. The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C.
Carneiro MV; Souza FF; Teixeira AC; Figueiredo JF; Villanova MG; Secaf M; Passos AD; Ramalho LN; Carneiro FP; Zucoloto S; Candolo Martinelli AL
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1204-10. PubMed ID: 20555268
[TBL] [Abstract][Full Text] [Related]
19. Analysis of HFE gene mutations (C282Y, H63D, and S65C) in the Ecuadorian population.
Leone PE; Giménez P; Collantes JC; Paz-y-Miño C
Ann Hematol; 2005 Feb; 84(2):103-5. PubMed ID: 15517265
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of HFE mutations in Japanese patients with chronic hepatitis C.
Ishizu Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
J Gastroenterol Hepatol; 2012 Jun; 27(6):1112-6. PubMed ID: 22098610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]